| Physical-Chemical Properties of Ozone - Natural Production of Ozone: The Toxicology of Ozone | p. 1 |
| Conclusions | p. 4 |
| How Ozone is Generated and its Concentrations Measured? | p. 5 |
| The Total Ozone Dose is Equivalent to the Gas Volume (ml) Multiplied by the Ozone Concentration (mcg/ml) | p. 6 |
| Conclusions | p. 8 |
| Preparation of Ozonated Water and Oil for the Topical Therapy - Ozone as a Drinking Water Disinfectant: Ozone Disinfection to Prevent Nosocomial Infections | p. 9 |
| Conclusions | p. 15 |
| How Does Ozone Act? How and Why can We Avoid Ozone Toxicity? | p. 17 |
| From Now on, Ozone is Exhausted and Only ROS (Mostly Hydrogen Peroxide) and LOPs are Responsible for the Successive and Multiple Biochemical Reactions Happening in Different Cells all Over the Body | p. 19 |
| Conclusions | p. 25 |
| How is Ozone Administered? | p. 27 |
| Conclusions | p. 33 |
| The Actual Six Therapeutic Modalities | p. 35 |
| Major Ozone Autohaemotherapy (AHT) | p. 35 |
| Minor Ozone Autohaemotherapy | p. 40 |
| The Biooxidative Therapy with Hydrogen Peroxide Dissolved in the Isotonic Glucose or Saline Solution. The Problem of the IV Infusion of Ozonated Saline and of Ozone Dissolved in Water. The Continuous Search of an Efficacious Blood's Substitute. Does the Ascorbate Solution Solve this Problem? | p. 42 |
| The Problem of Using Ozonated Saline | p. 47 |
| Rectal Insufflation of Oxygen-Ozone (RI) | p. 51 |
| Quasi-Total Body Exposure to Oxygen-Ozone (BOEX) | p. 57 |
| Extracorporeal Blood Circulation Against Oxygen-Ozone (EBOO) | p. 67 |
| Conclusions | p. 74 |
| The Potential Toxicity of Ozone: Side Effects and Contraindications of Ozonetherapy | p. 75 |
| Can Ozonetherapy Interfere with Conventional Treatment? | p. 81 |
| Are there Contraindications for Ozonetherapy? | p. 81 |
| Conclusions | p. 84 |
| Is Ozone Really a "Wonder Drug"? | p. 85 |
| Conclusions | p. 96 |
| The Clinical Application of Ozonetherapy | p. 97 |
| Infectious Diseases (Bacterial, Viral, Fungal, Parasitic) | p. 100 |
| Viral Infections | p. 106 |
| Ischaemic Diseases (Hind-Limb Ischaemia, Cerebral and Heart Ischaemia, Venous Stasis) | p. 122 |
| Retinal Degenerative Disorders | p. 133 |
| Neurodegenerative Diseases | p. 145 |
| Autoimmune Diseases. Can Ozone Therapy Do Better than Antibodies to TNF Alpha? | p. 149 |
| Ozonetherapy in Cancer | p. 162 |
| The Metabolic Syndrome and Ozonetherapy | p. 177 |
| What We Know About the Mechanisms of Hyperglycemia-Induced Damage? | p. 178 |
| Orthodox Therapies for the Metabolic Syndrome | p. 180 |
| Can Oxygen-Ozone Therapy Rebalance the Oxidative Stress and Stabilize the Metabolic Syndrome? | p. 181 |
| Experimental and Clinical Evidence that Ozonetherapy is Useful in Diabetes | p. 182 |
| Is any Haematological Disease Treatable with Ozone Therapy? | p. 184 |
| Can Ozone Therapy Slow Down the Progression of Oxidative Stress in Renal Diseases and Haemodialysis? | p. 190 |
| Dermatological Diseases and Ozone Therapy | p. 193 |
| Ozone Therapy in Pulmonary Diseases | p. 195 |
| The Problems of Tinnitus and Sudden Hearing Loss (SHL). Is Ozone Therapy of any Help? | p. 199 |
| The Paradoxical Effect of Ozone in Orthopaedic Diseases. The Problem of Back-Ache | p. 201 |
| A Therapeutic Option for Chronic Fatigue Syndrome (CFS) and Fibromyalgia | p. 210 |
| Ozone Therapy in Emergency Situations, Before Transplantation and Elective Surgery | p. 215 |
| Ozonetherapy in Dentistry and Stomatology | p. 217 |
| Ozonetherapy in Cosmetology | p. 219 |
| May Ozone Represent the Elixir of Life? | p. 222 |
| General Conclusions | p. 230 |
| The Dilemma Between Hyperbaric Oxygen Therapy (Hot) and Ozone Therapy | p. 233 |
| Conclusions | p. 236 |
| The Still Uncertain Future of Ozone Therapy in Medicine | p. 237 |
| Glossary | p. 241 |
| References | p. 253 |
| Index | p. 307 |
| Table of Contents provided by Ingram. All Rights Reserved. |